495 related articles for article (PubMed ID: 30171723)
1. Comparison between the effect of human Wharton's jelly-derived mesenchymal stem cells and levetiracetam on brain infarcts in rats.
Abd El Motteleb DM; Hussein S; Hasan MM; Mosaad H
J Cell Biochem; 2018 Dec; 119(12):9790-9800. PubMed ID: 30171723
[TBL] [Abstract][Full Text] [Related]
2. Retinoic acid-pretreated Wharton's jelly mesenchymal stem cells in combination with triiodothyronine improve expression of neurotrophic factors in the subventricular zone of the rat ischemic brain injury.
Sabbaghziarani F; Mortezaee K; Akbari M; Kashani IR; Soleimani M; Moini A; Ataeinejad N; Zendedel A; Hassanzadeh G
Metab Brain Dis; 2017 Feb; 32(1):185-193. PubMed ID: 27549229
[TBL] [Abstract][Full Text] [Related]
3. Priming Wharton's jelly-derived mesenchymal stromal/stem cells with ROCK inhibitor improves recovery in an intracerebral hemorrhage model.
Lee HS; Kim KS; Lim HS; Choi M; Kim HK; Ahn HY; Shin JC; Joe YA
J Cell Biochem; 2015 Feb; 116(2):310-9. PubMed ID: 25185536
[TBL] [Abstract][Full Text] [Related]
4. Treatment With Human Wharton's Jelly-Derived Mesenchymal Stem Cells Attenuates Sepsis-Induced Kidney Injury, Liver Injury, and Endothelial Dysfunction.
Cóndor JM; Rodrigues CE; Sousa Moreira Rd; Canale D; Volpini RA; Shimizu MH; Camara NO; Noronha Ide L; Andrade L
Stem Cells Transl Med; 2016 Aug; 5(8):1048-57. PubMed ID: 27280799
[TBL] [Abstract][Full Text] [Related]
5. Combined Wharton's jelly derived mesenchymal stem cells and nerve guidance conduit: A potential promising therapy for peripheral nerve injuries.
Shalaby SM; El-Shal AS; Ahmed FE; Shaban SF; Wahdan RA; Kandel WA; Senger MS
Int J Biochem Cell Biol; 2017 May; 86():67-76. PubMed ID: 28274689
[TBL] [Abstract][Full Text] [Related]
6. Wharton's jelly-derived mesenchymal stem cells attenuate sepsis-induced organ injury partially via cholinergic anti-inflammatory pathway activation.
Capcha JMC; Rodrigues CE; Moreira RS; Silveira MD; Dourado P; Dos Santos F; Irigoyen MC; Jensen L; Garnica MR; Noronha IL; Andrade L; Gomes SA
Am J Physiol Regul Integr Comp Physiol; 2020 Jan; 318(1):R135-R147. PubMed ID: 31596111
[TBL] [Abstract][Full Text] [Related]
7. Hydrogen peroxide preconditioning enhances the therapeutic efficacy of Wharton's Jelly mesenchymal stem cells after myocardial infarction.
Zhang J; Chen GH; Wang YW; Zhao J; Duan HF; Liao LM; Zhang XZ; Chen YD; Chen H
Chin Med J (Engl); 2012 Oct; 125(19):3472-8. PubMed ID: 23044308
[TBL] [Abstract][Full Text] [Related]
8. Wharton's Jelly Mesenchymal Stem Cells Protect the Immature Brain in Rats and Modulate Cell Fate.
Mueller M; Oppliger B; Joerger-Messerli M; Reinhart U; Barnea E; Paidas M; Kramer BW; Surbek DV; Schoeberlein A
Stem Cells Dev; 2017 Feb; 26(4):239-248. PubMed ID: 27842457
[TBL] [Abstract][Full Text] [Related]
9. Circular RNAs are abundantly expressed and upregulated during repair of the damaged endometrium by Wharton's jelly-derived mesenchymal stem cells.
Sun B; Shi L; Shi Q; Jiang Y; Su Z; Yang X; Zhang Y
Stem Cell Res Ther; 2018 Nov; 9(1):314. PubMed ID: 30442201
[TBL] [Abstract][Full Text] [Related]
10. An Injectable Hyaluronan-Methylcellulose (HAMC) Hydrogel Combined with Wharton's Jelly-Derived Mesenchymal Stromal Cells (WJ-MSCs) Promotes Degenerative Disc Repair.
Choi UY; Joshi HP; Payne S; Kim KT; Kyung JW; Choi H; Cooke MJ; Kwon SY; Roh EJ; Sohn S; Shoichet MS; Han I
Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33036383
[TBL] [Abstract][Full Text] [Related]
11. Wharton's Jelly-derived mesenchymal stem cells alleviate memory deficits and reduce amyloid-β deposition in an APP/PS1 transgenic mouse model.
Xie ZH; Liu Z; Zhang XR; Yang H; Wei LF; Wang Y; Xu SL; Sun L; Lai C; Bi JZ; Wang XY
Clin Exp Med; 2016 Feb; 16(1):89-98. PubMed ID: 26188488
[TBL] [Abstract][Full Text] [Related]
12. The Effect of Wharton Jelly-Derived Mesenchymal Stromal Cells and Their Conditioned Media in the Treatment of a Rat Spinal Cord Injury.
Chudickova M; Vackova I; Machova Urdzikova L; Jancova P; Kekulova K; Rehorova M; Turnovcova K; Jendelova P; Kubinova S
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31547264
[TBL] [Abstract][Full Text] [Related]
13. Possible Underlying Mechanisms for the Renoprotective Effect of Retinoic Acid-Pretreated Wharton's Jelly Mesenchymal Stem Cells against Renal Ischemia/Reperfusion Injury.
Barakat M; Hussein AM; Salama MF; Awadalla A; Barakat N; Serria M; El-Shafey M; El-Sherbiny M; El Adl MA
Cells; 2022 Jun; 11(13):. PubMed ID: 35805083
[TBL] [Abstract][Full Text] [Related]
14. Differential expression of cell cycle and WNT pathway-related genes accounts for differences in the growth and differentiation potential of Wharton's jelly and bone marrow-derived mesenchymal stem cells.
Batsali AK; Pontikoglou C; Koutroulakis D; Pavlaki KI; Damianaki A; Mavroudi I; Alpantaki K; Kouvidi E; Kontakis G; Papadaki HA
Stem Cell Res Ther; 2017 Apr; 8(1):102. PubMed ID: 28446235
[TBL] [Abstract][Full Text] [Related]
15. Wharton's jelly-derived mesenchymal stem cells promote myocardial regeneration and cardiac repair after miniswine acute myocardial infarction.
Zhang W; Liu XC; Yang L; Zhu DL; Zhang YD; Chen Y; Zhang HY
Coron Artery Dis; 2013 Nov; 24(7):549-58. PubMed ID: 23892469
[TBL] [Abstract][Full Text] [Related]
16. Single high-dose intravenous injection of Wharton's jelly-derived mesenchymal stem cell exerts protective effects in a rat model of metabolic syndrome.
Chan AML; Ng AMH; Yunus MHM; Idrus RH; Law JX; Yazid MD; Chin KY; Yusof MRM; Ng SN; Koh B; Lokanathan Y
Stem Cell Res Ther; 2024 Jun; 15(1):160. PubMed ID: 38835014
[TBL] [Abstract][Full Text] [Related]
17. Mesenchymal stromal cells from umbilical cord Wharton's jelly trigger oligodendroglial differentiation in neural progenitor cells through cell-to-cell contact.
Oppliger B; Joerger-Messerli MS; Simillion C; Mueller M; Surbek DV; Schoeberlein A
Cytotherapy; 2017 Jul; 19(7):829-838. PubMed ID: 28457739
[TBL] [Abstract][Full Text] [Related]
18. Transplantation of human bone marrow mesenchymal stromal cells reduces liver fibrosis more effectively than Wharton's jelly mesenchymal stromal cells.
Rengasamy M; Singh G; Fakharuzi NA; Siddikuzzaman ; Balasubramanian S; Swamynathan P; Thej C; Sasidharan G; Gupta PK; Das AK; Rahman AZA; Fakiruddin KS; Nian LM; Zakaria Z; Majumdar AS
Stem Cell Res Ther; 2017 Jun; 8(1):143. PubMed ID: 28610623
[TBL] [Abstract][Full Text] [Related]
19. Human Wharton's Jelly-Derived Stem Cells Display Immunomodulatory Properties and Transiently Improve Rat Experimental Autoimmune Encephalomyelitis.
Donders R; Vanheusden M; Bogie JF; Ravanidis S; Thewissen K; Stinissen P; Gyselaers W; Hendriks JJ; Hellings N
Cell Transplant; 2015; 24(10):2077-98. PubMed ID: 25310756
[TBL] [Abstract][Full Text] [Related]
20. Wharton's Jelly-Derived Mesenchymal Stem Cell Transplantation in a Patient with Hypoxic-Ischemic Encephalopathy: A Pilot Study.
Kabataş S; Civelek E; İnci Ç; Yalçınkaya EY; Günel G; Kır G; Albayrak E; Öztürk E; Adaş G; Karaöz E
Cell Transplant; 2018 Oct; 27(10):1425-1433. PubMed ID: 30203688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
